MediSpend Reports Exponential Growth in 2021

Portsmouth, NH — MediSpend, a global technology company providing best-in-class solutions that empower life sciences companies to grow their business compliantly, reports another year of record-breaking growth with the addition of various new clients totaling nearly 150 life sciences companies leveraging the MediSpend Global Compliance Suite. With support from their new investor, Susquehanna Growth Equity, MediSpend was able to focus significant investment into product development in 2021.

“As a trusted partner, the MediSpend team focuses on how to best support life sciences companies in their pursuit to grow their business compliantly,” said Craig Hauben, CEO of MediSpend. “We experienced another tremendous year with continued innovation, high client satisfaction scores, a strong partner ecosystem and a dedicated team exceeding client expectations.”

Product innovation has been a key focus for MediSpend. They have doubled their investment into Engagement Manager and have continued to expand Transparency Solution to include automated reporting with additional countries. Within these two flagship products, new data-driven insights have been developed to enable clients to make more informed business decisions while mitigating risk.

With high client satisfaction scores of 94% and 97% client retention, the demand for MediSpend solutions is at an all-time high. More than 37 life sciences companies expanded their MediSpend partnership by purchasing additional MediSpend solutions this year.

“Engagement Manager and Transparency Solution continue to maintain market leading positions while our Grants Management Solution is quickly becoming the choice among medical affairs organizations to manage their entire funding request programs,” said Seth Houston, chief commercial officer of MediSpend. “Engagement Manager enables your business to plan, engage and pay HCP/Os for activities that meet company objectives using embedded rules. Transparency Solution automatically aggregates, validates and reports transfers of value to comply with all global laws and codes. Our Grants Management Solution helps life sciences companies simplify and streamline their funding request processes from initial submission through closeout. Each of our solutions are specifically built with the guardrails that compliance requires which enable their commercial counterparts to execute their plans without risk of non-compliance.”

The MediSpend Partner Program has grown exceptionally over the year. MediSpend partners continue to complement MediSpend solutions through innovative technology, professional and advisory services. 10 strategic partners now partner with MediSpend to combine services to achieve mutual client success.

Additional Information
For more on MediSpend, visit:
To stay on top of the latest industry news and MediSpend product launches, connect with MediSpend on LinkedIn.


About MediSpend
MediSpend is a global technology company providing best-in-class solutions that empower life science companies to grow their business compliantly through top-rated software and client services. MediSpend is the compliance system of record for some of the world’s largest pharmaceutical, medical device, dental and emerging biotech companies around the world. The MediSpend Global Compliance Suite represents the industry’s first global SaaS solution purpose-built to manage the end-to-end process of HCP engagement through transparency reporting, which includes software that facilitates external grant requests. MediSpend is headquartered in Portsmouth, N.H., with offices in Minnesota, New York, Pennsylvania and the Netherlands. Visit MediSpend online at

Media Contact:
Seth Houston
(215) 779-2415

Seth Houston

Chief Commercial Officer

Posted on Jan 18, 2022 12:49:53 PM

Share This Story, Choose Your Platform!


Want to stay updated on news and events?




Want to learn more about how our solutions can help your company?